
Social media hype around Alzheimer's blood tests risks anxiety and misdiagnosis
Researchers warn that social media promotion of Alzheimer's blood biomarker tests (e.g., p-tau217/181) can lure asymptomatic people into unnecessary testing, triggering anxiety and possible misdiagnosis since a positive biomarker does not guarantee future dementia; experts urge use only with clinical assessment and caution against screening healthy individuals, noting costs, potential harms, and unclear next steps.










